Patient sociodemographic and clinical characteristics
| Characteristic . | N = 360 n (%) . |
|---|---|
| Site | |
| Massachusetts General Hospital, Boston, MA | 179 (49.7) |
| Duke University Hospital, Durham, NC | 99 (27.5) |
| Fred Hutchinson Cancer Research Center, Seattle, WA | 82 (22.8) |
| Age (y), mean (SD) | 55.4 (12.5) |
| Female | 137 (38.1) |
| Race | |
| White | 278 (77.2) |
| African American | 39 (10.8) |
| Asian | 20 (5.6) |
| American Indian | 7 (1.9) |
| Missing | 16 (4.4) |
| Hispanic ethnicity | 17 (4.7) |
| Relationship status | |
| Married or cohabitating | 254 (70.6) |
| Noncohabitating relationship | 11 (3.1) |
| Single, never married | 42 (11.7) |
| Divorced or separated | 35 (9.7) |
| Widowed | 13 (3.6) |
| Missing | 5 (1.4) |
| Live alone | 52 (14.4) |
| Highest education level | |
| Did not complete high school | 8 (2.2) |
| High school degree or equivalent | 67 (18.6) |
| Some college | 58 (16.1) |
| Associate degree | 36 (10.0) |
| College degree | 90 (25.0) |
| Advanced graduate degree | 97 (27.0) |
| Missing | 4 (1.1) |
| Employment | |
| Full or part-time work | 143 (39.7) |
| Unemployed, illness or disability | 105 (29.2) |
| Unemployed, looking for work | 6 (1.7) |
| Unemployed, not looking for work | 12 (3.3) |
| Student | 4 (1.1) |
| Retired | 83 (23.1) |
| Missing | 7 (1.9) |
| ECOG PS | |
| 0 | 176 (48.9) |
| 1 | 167 (46.4) |
| 2 | 7 (1.9) |
| Missing | 10 (2.8) |
| Diagnosis | |
| Multiple myeloma | 111 (30.8) |
| Acute leukemia (AML, ALL) | 89 (24.7) |
| Lymphoma | 88 (24.4) |
| MDS/MPN/CML | 68 (18.9) |
| Other | 4 (1.1) |
| Transplantation type | |
| Myeloablative, autologous | 179 (49.7) |
| Myeloablative, allogeneic | 119 (33.1) |
| Reduced intensity, allogeneic | 62 (17.2) |
| Transplantation donor | |
| Autologous | 179 (49.7) |
| Matched related | 45 (12.5) |
| Matched unrelated | 101 (28.1) |
| Mismatched | 15 (4.2) |
| Cord | 20 (5.6) |
| Disease status at HCT | |
| Complete response | 163 (45.3) |
| Partial response | 130 (36.1) |
| Refractory disease | 55 (15.3) |
| Untreated | 9 (2.5) |
| Missing | 3 (0.8) |
| Characteristic . | N = 360 n (%) . |
|---|---|
| Site | |
| Massachusetts General Hospital, Boston, MA | 179 (49.7) |
| Duke University Hospital, Durham, NC | 99 (27.5) |
| Fred Hutchinson Cancer Research Center, Seattle, WA | 82 (22.8) |
| Age (y), mean (SD) | 55.4 (12.5) |
| Female | 137 (38.1) |
| Race | |
| White | 278 (77.2) |
| African American | 39 (10.8) |
| Asian | 20 (5.6) |
| American Indian | 7 (1.9) |
| Missing | 16 (4.4) |
| Hispanic ethnicity | 17 (4.7) |
| Relationship status | |
| Married or cohabitating | 254 (70.6) |
| Noncohabitating relationship | 11 (3.1) |
| Single, never married | 42 (11.7) |
| Divorced or separated | 35 (9.7) |
| Widowed | 13 (3.6) |
| Missing | 5 (1.4) |
| Live alone | 52 (14.4) |
| Highest education level | |
| Did not complete high school | 8 (2.2) |
| High school degree or equivalent | 67 (18.6) |
| Some college | 58 (16.1) |
| Associate degree | 36 (10.0) |
| College degree | 90 (25.0) |
| Advanced graduate degree | 97 (27.0) |
| Missing | 4 (1.1) |
| Employment | |
| Full or part-time work | 143 (39.7) |
| Unemployed, illness or disability | 105 (29.2) |
| Unemployed, looking for work | 6 (1.7) |
| Unemployed, not looking for work | 12 (3.3) |
| Student | 4 (1.1) |
| Retired | 83 (23.1) |
| Missing | 7 (1.9) |
| ECOG PS | |
| 0 | 176 (48.9) |
| 1 | 167 (46.4) |
| 2 | 7 (1.9) |
| Missing | 10 (2.8) |
| Diagnosis | |
| Multiple myeloma | 111 (30.8) |
| Acute leukemia (AML, ALL) | 89 (24.7) |
| Lymphoma | 88 (24.4) |
| MDS/MPN/CML | 68 (18.9) |
| Other | 4 (1.1) |
| Transplantation type | |
| Myeloablative, autologous | 179 (49.7) |
| Myeloablative, allogeneic | 119 (33.1) |
| Reduced intensity, allogeneic | 62 (17.2) |
| Transplantation donor | |
| Autologous | 179 (49.7) |
| Matched related | 45 (12.5) |
| Matched unrelated | 101 (28.1) |
| Mismatched | 15 (4.2) |
| Cord | 20 (5.6) |
| Disease status at HCT | |
| Complete response | 163 (45.3) |
| Partial response | 130 (36.1) |
| Refractory disease | 55 (15.3) |
| Untreated | 9 (2.5) |
| Missing | 3 (0.8) |
ALL, acute lymphoblastic leukemia; AML, acute myeloid leukemia; CML, chronic myeloid leukemia; ECOG PS, Eastern Cooperative Oncology Group performance status; MDS, myelodysplastic syndrome; MPN, myeloproliferative neoplasm.